Report #2857399

Received Sep 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	—

Symptoms (1)

Product administered at inappropriate site

Symptom narrative

received the first dose of the vaccine shingrix in my gluteus; This non-serious case was reported by a consumer via call center representative and described the occurrence of vaccine administered at inappropriate site in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced vaccine administered at inappropriate site (Verbatim: received the first dose of the vaccine shingrix in my gluteus). The outcome of the vaccine administered at inappropriate site was not applicable. Additional Information: GSK Receipt Date: 27-AUG-2025 The patient received the first dose of the vaccine Shingrix in gluteus which led to vaccine administered at inappropriate site.